MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.410
- +0.100+1.07%
Close Jan 3 16:00 ET
- 9.410
- 0.0000.00%
Post 20:01 ET
2.81BMarket Cap-27.68P/E (TTM)
9.520High9.270Low1.69MVolume9.320Open9.310Pre Close15.95MTurnover0.69%Turnover RatioLossP/E (Static)298.81MShares14.09052wk High15.74P/B2.31BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM2.69%Amplitude1.765Historical Low9.420Avg Price1Lot Size
Amicus Therapeutics News
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(5.1%),Jeremy C. Green(5.1%)
Amicus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-William Blair Investment Management, LLC(5.3%)
Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(7.8%),Behzad Aghazadeh(7.8%)
Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.08%),Wellington Group Holdings LLP(8.08%), etc.
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 10-Q: Q3 2024 Earnings Report
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 8-K: Current report
Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.3%)
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L
Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Harford Simon N.R.
Amicus Therapeutics | 10-Q: Q2 2024 Earnings Report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.